Table 3.
CyD type | Active molecule | Release data | Ref |
---|---|---|---|
HP-β-CyD, HP-γ-CyD |
Triclosan | Rapid release on contact with water and significant inhibition against E. coli and S. aureus | [165] |
HP-β-CyD, HP-γ-CyD |
Camphor | In gas phase, faster release at higher temp., faster for the HP-β-CyD system | [166] |
HP-β-CyD, HP-γ-CyD, and M-β-CyD |
Eugenol | Rapid release on contact with water, enhanced antioxidant activity than eugenol itself | [167] |
HP-β-CyD, HP-γ-CyD |
Cineole and p-cymene | Rapid release along with the fiber dissolution | [168] |
HP-β-CyD, HP-γ-CyD, and M-β-CyD |
Linalool | Rapid release, significant inhibition against the growth of E. coli and S. aureus | [169] |
HP-β-CyD, HP-γ-CyD and M-β-CyD |
Limonene | 25% Release M-β-CyD/limonene-IC-NF, 51% release HP-β-CyD/limonene-IC-NF, 88% release HP-γ-CyD/limonene-IC-NF in 100 days | [170] |
HP-β-CyD, HP-γ-CyD and M-β-CyD |
Geraniol | Long-term stability of geraniol in gas phase | [171] |
HP-β-CyD, HP-γ-CyD and M-β-CyD |
Thymol | Immediately on contact with water | [172] |
HP-β-CyD, HP-γ-CyD |
Menthol | Rapid release along with the fiber dissolution | [173] |
HP-β-CyD, HP-γ-CyD and M-β-CyD |
Vanillin | Immediately on contact with water, enhanced antioxidant activity with nanofibers | [174] |
HP-β-CyD | Vitamin E | Rapid and enhanced release, higher antioxidant activity with CyD | [175] |
HP-β-CyD, HP-β-CyD |
Carvacrol | Rapid release on contact with water | [176] |
SBE7-β-CyD | Sulfisoxazole | Rapid and enhanced release of sulfisoxazole on contact with water | [179] |
HP-β-CyD | Diclofenac sodium | Release in few minutes | [180] |
HP-β-CyD | Spironolactone | Total release in 1 h | [181] |
Phenylacetic-β-CyD | Doxorubicin, fluorescein isothiocyanate-dextran (FITC-dextran), recombinant human insulin (FITC-labeled insulin) and chlorin e6 | 50% Release of drugs in vitro in 30 days, ~100% release of chlorin in vivo on day 28 | [182] |